Elequin Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Elequin Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,800	Closed	-$28K	–	927
2022 Q3	$28K	Buy	+2,800	New	+$27.8K	0.01%	128

Elequin Capital's FLAC Position: Q4 2022 in Review

Elequin Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 2,800 shares — an estimated $28K sold.

Elequin Capital first reported a position in FLAC in Q3 2022 and held it in 1 quarter. The position peaked at $28K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Elequin Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Elequin Capital sold 2,800 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $28K.
Elequin Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q3 2022 and held it in 1 quarter.
Elequin Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $28K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.